Form EFFECT Semnur Pharmaceuticals,

May 19, 2026 6:05 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 18, 2026
Accession Number: 0001193125-26-219654
Submission Type: POS AM
CIK: 0001913577
Company Name: Semnur Pharmaceuticals, Inc.
File Number: 333-290995


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings